Citizens JMP raised the firm’s price target on American Healthcare REIT (AHR) to $45 from $40 and keeps an Outperform rating on the shares. The company reported a “beat and raise” Q2, the analyst tells investors in a research note. The firm believes the investment story “has legs for multiple years to come” and continues to recommend the stock.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT Faces Risks from New Tax Legislation and Medicaid Cuts
- American Healthcare REIT Reports Strong Q2 2025 Results
- American Healthcare REIT’s New $1 Billion Equity Offering
- American Healthcare REIT reports Q2 FFO 42c, consensus 40c
- American Healthcare REIT raises 2025 FFO outlook to $1.64-$1.68, consensus $1.65